Bryony Simmons is a Research Fellow at LSE Health. Her research focuses on the economics of access to essential medicines and diagnostics, particularly in African health systems. She uses quantitative approaches, including economic evaluations, stated preference methods, and quasi-experimental designs, to generate evidence that can inform resource allocation and health policy decisions.

Bryony’s current research centres on the EChiLiBRiST consortium, an EU-funded programme working to improve the management of childhood fever. Within this project, Bryony co-leads the health economics workstream alongside Dr Lesong Conteh, collaborating with partners across Africa and Europe to understand how new diagnostic and prognostic tools can support clinical decision-making, evaluate their value for money, and assess how they are perceived by end users. She is also involved in projects exploring the digitalisation of seasonal malaria chemoprevention campaigns in Mozambique, in collaboration with Malaria Consortium, and DIAGMAL, an EU-funded initiative focused on malaria diagnostics.

Before joining LSE, Bryony held positions at Imperial College London and the Clinton Health Access Initiative in Rwanda. She continues to provide statistical support for clinical studies across Europe and Africa. She holds a PhD from Imperial College London.